-
Musk 'wanted 90%' of OpenAI, Altman says in high-stakes trial
-
US appeals court halts order declaring Trump's global 10% tariff illegal
-
Rubio, with new Chinese name, heads to Beijing despite sanctions
-
Showtime as boycotted Eurovision kicks off
-
Stars descend as Cannes Film Festival opens without Hollywood backing
-
No.1 Scheffler to start PGA with Rose and Matt Fitzpatrick
-
Trump heads to China for superpower summit
-
Referees' chief says disallowing Hammers goal against Arsenal 'categorically' right
-
Brazil's Lula launches plan to fight organized crime ahead of elections
year
-
Grizzlies forward Brandon Clarke dies at 29: team
-
No.5 Morikawa still battles back issues as PGA start looms
-
Stadium changes just part of Houston's World Cup transformation
-
Trump announces departure of food and drug regulation chief
-
Russia demands closure of high representative post in Bosnia
-
Rabada stars as Gujarat hammer Hyderabad to move top of IPL
-
Kevin Warsh returns to Federal Reserve with 'regime change' agenda
-
Former Georgia rugby captain Sharikadze banned over urine-swap scheme
-
Fabled Argentine city Ushuaia tries to shrug off virus suspicions
-
Pentagon says US cost of Iran war nearing $29 billion
-
Wild peacocks bring delight, despair to Italian village
-
Murray to coach British star Draper in run-up to Wimbledon
-
Dick Advocaat returns as Curacao coach for World Cup
-
Real Madrid president Perez calls club elections, will stand again
-
Prosecutors granted access to Woods's prescription records in DUI crash case
-
US Senate confirms Trump-nominee Warsh to Federal Reserve board
-
Former Ecuadoran top diplomat enters race for UN chief
-
Wine consumption slides in 2025
-
Trump due in China for superpower summit with Xi
-
Narvaez wins Giro stage four as Ciccone takes leader's pink jersey
-
Russia tests long-range missile after US nuclear treaty expires
-
Sinner dismisses Pellegrino to reach Italian Open quarters, Zverev out
-
UK PM Starmer resists calls to quit as Labour divided
-
'Shame on Hollywood': Cannes-winning writer rails at stance on Gaza
-
Singaporean, Indian firms face criminal charges over Maryland bridge crash
-
Arsenal's White out for rest of the season with knee injury
-
Germany wants to put TikTok 'in European hands'
-
Rahm has faith LIV will develop good survival plan
-
Sinner dismisses Pellegrino to reach Italian Open quarter-finals
-
Sam Altman to testify at California tech titan trial
-
McIlroy has 'clear road ahead' to win more majors
-
Rome derby row as authorities reschedule Serie A to avoid tennis clash
-
Georgia enthrones new leader of powerful Orthodox Church
-
French court convicts VW for 'consumer harm' in 'Dieselgate' scandal
-
US consumer inflation hits three-year high fuelled by Iran war
-
Cannes honours Jackson, Middle Earth wizard who 'transformed' cinema
-
Vladimir Weiss returns as Slovakia coach
-
Iran says US must accept peace plan or face 'failure'
-
UK PM Starmer defiant as calls to quit grow
-
Spain coach counting on Yamal and Williams fitness for World Cup
-
Guardiola says Man City 'still fighting' for Premier League title
Trump announces departure of food and drug regulation chief
President Donald Trump said Tuesday his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency.
During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes.
"Marty is a terrific guy, but he's going to go on, and he's going to lead a good life," Trump said, speaking to journalists who pressed him on the reported resignation that comes after weeks of rumors that the president planned to fire his FDA commissioner.
Makary, a surgeon and former Fox News contributor, made waves during the Covid-19 pandemic as an outspoken critic of the medical establishment and the health measures of the time.
He took over the FDA promising reform. He leaves just over a year later, facing criticism from all angles, including from pharmaceutical executives, tobacco lobbyists, and anti-abortion activists.
Conservatives against the abortion pill mifepristone accuse Makary of taking too long to complete and issue a review of the drug that's been FDA-approved for 25 years, but which they continue to target.
The Trump administration meanwhile forged ahead with a policy allowing for the sale of flavored e-cigarettes despite resistance from Makary, who had voiced concern over the appeal of the vapes to youth.
Many pharmaceutical executives said Makary's initiatives to shake up the drug review process had only created more problems.
And public health leaders accused him of catering to anti-vaccine activists after the FDA put out an unsupported memo claiming deaths linked to the Covid-19 vaccine.
It's the latest in a string of shake-ups at the health department overseen by noted vaccine skeptic Robert F. Kennedy Jr, with figures seen as more conventional put forth as nominees to be surgeon general as well as helm the Centers for Disease Control and Prevention.
Y.Nakamura--AMWN